A new Ebola vaccine is set to enter human trials after being given the green light by UK regulators. Scientists from the University of Oxford kicked off the development just eight weeks ago, following a public health emergency declaration on May 17. This vaccine is the first of four in development to reach this critical stage. Right now, they’re looking for volunteers, with the first doses expected to be administered to healthy adults in the UK “within weeks.”
The trial will involve 50 healthy adults aged between 18 and 55. Meanwhile, researchers are teaming up with partners in Uganda to lay the groundwork for trials in Africa, where the need for effective vaccines is crucial. Volunteers will be closely monitored for an entire year. However, scientists anticipate being able to determine relatively quickly whether the vaccine can trigger the desired immune response or if it produces any unexpected side effects.
What’s exciting is how the Oxford team managed to whip up this vaccine in such a short time – they’re utilizing the same tech that gained fame during the Covid pandemic, specifically the platform used for the Oxford/AstraZeneca Covid vaccine. This innovative approach employs a common cold virus that infects chimpanzees, which has been genetically modified to ensure it’s safe. Think of it like sending a letter in an envelope – the researchers just need to swap out the message inside before delivering it to the body. For Covid, that message was a snippet of the virus’s genetic code.
Now, the Medicines and Healthcare Products Regulatory Agency has officially approved the commencement of human trials. Vaccine researcher Alex Sampson shared with the BBC that typically, vaccines can take up to a decade to research, develop, and prove effective. However, he emphasizes that no corners are being cut, stating, “We are able to do them in parallel, so it means a lot of teams working in lots of different places around the clock, but we’re still doing everything that we would normally do.”
He also stressed the importance of safety, reminding everyone that the Covid AstraZeneca vaccine was given to millions of people without issues. In a heartfelt moment, he reflected on his personal loss, saying, “I buried my parents one day after the other.”
The urgency behind this trial is palpable, and one can’t help but wonder how quickly we might see results. Will this vaccine be able to fend off the deadly Ebola virus effectively? Only time will tell…
Kaynak: Orijinal Haber